Aravind R. Sanjeevaiah, MD, discusses the benefit of immunotherapy agents in the treatment of patients with gastric cancers.
Aravind R. Sanjeevaiah, MD
Advertisement
Articles by Aravind R. Sanjeevaiah, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
MONUMENTAL-3 Data Support Talquetamab Plus Daratumumab ± Pomalidomide as a New SOC in R/R Myeloma
2
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
3
Luspatercept Misses Primary RBC-TI End Point But Shows Clinically Meaningful Improvement for Anemia in Myelofibrosis
4
CLL14 Final Analysis Shows Long-Term PFS Gain With Venetoclax/Obinutuzumab in Previously Untreated CLL
5